{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:12:05Z","timestamp":1791306725516,"version":"4.3.1"},"reference-count":99,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.molmed.2010.03.002","type":"journal-article","created":{"date-parts":[[2010,4,18]],"date-time":"2010-04-18T15:01:36Z","timestamp":1271602896000},"page":"218-229","source":"Crossref","is-referenced-by-count":157,"title":["HIV-associated lipodystrophy: from fat injury to premature aging"],"prefix":"10.1016","volume":"16","author":[{"given":"Martine","family":"Caron-Debarle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Lagathu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Boccara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Vigouroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Capeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2010.03.002_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2010.03.002_bib2","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(00)02854-3","article-title":"Adverse effects of antiretroviral therapy","volume":"356","author":"Carr","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2010.03.002_bib3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/COH.0b013e3281c10df7","article-title":"Adipose tissue inflammation and altered adipokine and cytokine production in antiretroviral therapy-associated lipodystrophy","volume":"2","author":"Hammond","year":"2007","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.molmed.2010.03.002_bib4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/COH.0b013e32814b1638","article-title":"Adipocyte dysfunction in response to antiretroviral therapy: clinical, tissue and in-vitro studies","volume":"2","author":"Caron","year":"2007","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.molmed.2010.03.002_bib5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbalip.2009.09.018","article-title":"Drug-induced lipotoxicity: lipodystrophy associated with HIV-1 infection and antiretroviral treatment","volume":"180","author":"Villarroya","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2010.03.002_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1468-1293.2007.00537.x","article-title":"Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006","volume":"9","author":"Nguyen","year":"2008","journal-title":"HIV Med."},{"key":"10.1016\/j.molmed.2010.03.002_bib7","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/QAD.0b013e32832b7e69","article-title":"Longitudinal changes in regional fat content in HIV-infected children and adolescents","volume":"23","author":"Arpadi","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2010.03.002_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jac\/dkp240","article-title":"Evolving perspectives on HIV-associated lipodystrophy syndrome: moving from lipodystrophy to non-infectious HIV co-morbidities","volume":"64","author":"Guaraldi","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.molmed.2010.03.002_bib9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nature05483","article-title":"Adipocytes as regulators of energy balance and glucose homeostasis","volume":"444","author":"Rosen","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2010.03.002_bib10","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1210\/jc.2009-0925","article-title":"Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss","volume":"94","author":"Aron-Wisnewsky","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2010.03.002_bib11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2353\/ajpath.2009.081155","article-title":"Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations","volume":"175","author":"De Pauw","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2010.03.002_bib12","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.2337\/db07-0510","article-title":"Essential role of mitochondrial function in adiponectin synthesis in adipocytes","volume":"56","author":"Koh","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.molmed.2010.03.002_bib13","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2008.08.068","article-title":"Oxidative stress induced lipid accumulation via SREBP1c activation in HepG2 cells","volume":"375","author":"Sekiya","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2010.03.002_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/B:MCBI.0000049374.52989.9b","article-title":"Regional differences in oxidative capacity of rat white adipose tissue are linked to the mitochondrial content of mature adipocytes","volume":"267","author":"Deveaud","year":"2004","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.molmed.2010.03.002_bib15","doi-asserted-by":"crossref","first-page":"E1072","DOI":"10.1152\/ajpendo.00206.2003","article-title":"Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels","volume":"285","author":"Lihn","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2010.03.002_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/MOL.0b013e328321b3a8","article-title":"Ectopic lipids and organ function","volume":"20","author":"Szendroedi","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.molmed.2010.03.002_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.ATV.0000251608.09329.9a","article-title":"Role of the Toll-like receptor 4\/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages","volume":"27","author":"Suganami","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.molmed.2010.03.002_bib18","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1038\/oby.2009.152","article-title":"Mitochondrial DNA: an up-and-coming actor in white adipose tissue pathophysiology","volume":"17","author":"Villarroya","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.molmed.2010.03.002_bib19","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2010.03.002_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbalip.2008.12.014","article-title":"Lipodystrophies: disorders of adipose tissue biology","volume":"1791","author":"Garg","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2010.03.002_bib21","doi-asserted-by":"crossref","unstructured":"Capeau, J. et al. (2010) Human lipodystrophies: genetic and acquired diseases of adipose tissue. In Adipose Tissue Development: From Animal Models to Clinical Conditions. (Levy-Marchal, C., P\u00e9nicaud, L., eds), pp. 1\u201320, Endocr Dev. Basel, Karger","DOI":"10.1159\/000316893"},{"key":"10.1016\/j.molmed.2010.03.002_bib22","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.biochi.2009.01.011","article-title":"Seipin deficiency alters fatty acid Delta9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy","volume":"91","author":"Boutet","year":"2009","journal-title":"Biochimie."},{"key":"10.1016\/j.molmed.2010.03.002_bib23","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1172\/JCI37679","article-title":"Laminopathies and the long strange trip from basic cell biology to therapy","volume":"119","author":"Worman","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2010.03.002_bib24","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/sj.cdd.4402197","article-title":"Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence","volume":"14","author":"Caron","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molmed.2010.03.002_bib25","first-page":"S254","article-title":"Remodeling of adipose tissue from lipodystrophic patients with LMNA mutations: presence of fibrosis and mitochondrial alterations but no inflammation","volume":"251","author":"B\u00e9r\u00e9ziat","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmed.2010.03.002_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.mce.2009.09.024","article-title":"Obesity and corticosteroids: 11beta-Hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease","volume":"316","author":"Morton","year":"2009","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.molmed.2010.03.002_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1468-1293.2003.00159.x","article-title":"HIV lipodystrophy: prevalence, severity and correlates of risk in Australia","volume":"4","author":"Miller","year":"2003","journal-title":"HIV Med."},{"key":"10.1016\/j.molmed.2010.03.002_bib28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/135965350300800614","article-title":"Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level","volume":"8","author":"Nolan","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.molmed.2010.03.002_bib29","doi-asserted-by":"crossref","first-page":"e5647","DOI":"10.1371\/journal.pone.0005647","article-title":"Zidovudine\/lamivudine for HIV-1 infection contributes to limb fat loss","volume":"4","author":"van Vonderen","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2010.03.002_bib30","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bbabio.2006.05.001","article-title":"Anti-HIV drugs and the mitochondria","volume":"1757","author":"Pinti","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2010.03.002_bib31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/COH.0b013e3281df3410","article-title":"Mechanisms of antiretroviral therapy-induced mitochondrial dysfunction","volume":"2","author":"Cote","year":"2007","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.molmed.2010.03.002_bib32","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3851\/IMP1457","article-title":"Adipocyte differentiation, mitochondrial gene expression and fat distribution: differences between zidovudine and tenofovir after 6 months","volume":"14","author":"Boothby","year":"2009","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.molmed.2010.03.002_bib33","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/01.aids.0000183629.20041.bb","article-title":"Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides","volume":"19","author":"Dube","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2010.03.002_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/QAI.0b013e31816856ed","article-title":"Long-term subcutaneous tissue changes among antiretroviral-naive persons initiating stavudine, zidovudine, or abacavir with lamivudine","volume":"48","author":"Shlay","year":"2008","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.molmed.2010.03.002_bib35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/COH.0b013e3281e72ca0","article-title":"Antiretroviral therapy-induced lipid alterations: in-vitro, animal and human studies","volume":"2","author":"Mallon","year":"2007","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.molmed.2010.03.002_bib36","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1001\/archinte.162.22.2621","article-title":"Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study","volume":"162","author":"Galli","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.molmed.2010.03.002_bib37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0192623308327119","article-title":"The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications","volume":"37","author":"Flint","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.molmed.2010.03.002_bib38","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/QAD.0b013e32832b4377","article-title":"Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment","volume":"23","author":"Haubrich","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2010.03.002_bib39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00126334-200309010-00008","article-title":"Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns","volume":"34","author":"Galli","year":"2003","journal-title":"J. Acquir. Immune. Defic. Syndr."},{"key":"10.1016\/j.molmed.2010.03.002_bib40","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1086\/430379","article-title":"Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women","volume":"40","author":"Jacobson","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2010.03.002_bib41","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1086\/597776","article-title":"Changes in body composition with ritonavir-boosted and unboosted atazanavir treatment in combination with Lamivudine and Stavudine: a 96-week randomized, controlled study","volume":"48","author":"McComsey","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2010.03.002_bib42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.beem.2007.04.007","article-title":"Sexual dimorphism of body composition","volume":"21","author":"Wells","year":"2007","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2010.03.002_bib43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/AAC.00914-09","article-title":"Mitochondrial DNA depletion and respiratory chain activity in primary human subcutaneous adipocytes treated with nucleoside analogue reverse transcriptase inhibitors","volume":"54","author":"Stankov","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molmed.2010.03.002_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/135965350801300103","article-title":"Contribution of mitochondrial dysfunction and oxidative stress to cellular premature senescence induced by antiretroviral thymidine analogues","volume":"13","author":"Caron","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.molmed.2010.03.002_bib45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/135965350601100109","article-title":"Uridine abrogates the adverse effects of antiretroviral pyrimidine analogues on adipose cell functions","volume":"11","author":"Walker","year":"2006","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.molmed.2010.03.002_bib46","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/135965350701200407","article-title":"Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages","volume":"12","author":"Lagathu","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.molmed.2010.03.002_bib47","doi-asserted-by":"crossref","first-page":"15130","DOI":"10.1074\/jbc.M312875200","article-title":"In vitro suppression of the lipogenic pathway by the nonnucleoside reverse transcriptase inhibitor efavirenz in 3T3 and human preadipocytes or adipocytes","volume":"279","author":"El Hadri","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2010.03.002_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbrc.2009.05.148","article-title":"Lopinavir co-induces insulin resistance and ER stress in human adipocytes","volume":"386","author":"Djedaini","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2010.03.002_bib49","doi-asserted-by":"crossref","first-page":"E315","DOI":"10.1152\/ajpendo.90486.2008","article-title":"Depot-specific adipocyte cell lines reveal differential drug-induced responses of white adipocytes--relevance for partial lipodystrophy","volume":"296","author":"Kovsan","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"Suppl. 4","key":"10.1016\/j.molmed.2010.03.002_bib50","first-page":"A15","article-title":"HIV protease inhibitors differently affect human subcutaneous and visceral fat: they induce IL-6 production and alter lipid storage capacity in subcutaneous but nos visceral adipose tissue explants","volume":"13","author":"Vatier","year":"2008","journal-title":"Antiviral Therapy"},{"key":"10.1016\/j.molmed.2010.03.002_bib51","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1189\/jlb.0809580","article-title":"The macrophage: the intersection between HIV infection and atherosclerosis","volume":"87","author":"Crowe","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.molmed.2010.03.002_bib52","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/135965350601100610","article-title":"HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV-1\/HAART-associated lipodystrophy","volume":"11","author":"Giralt","year":"2006","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.molmed.2010.03.002_bib53","first-page":"4","article-title":"Recent advances in the relationship between obesity, inflammation, and insulin resistance","volume":"17","author":"Bastard","year":"2006","journal-title":"Eur. Cytokine. Netw."},{"key":"10.1016\/j.molmed.2010.03.002_bib54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00002030-200401230-00007","article-title":"HIV-1 Nef protein in the nucleus influences adipogenesis as well as viral transcription through the peroxisome proliferator-activated receptors","volume":"18","author":"Otake","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2010.03.002_bib55","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/me.2007-0124","article-title":"Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor {gamma} and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy","volume":"22","author":"Shrivastav","year":"2008","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.molmed.2010.03.002_bib56","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/135965350801300511","article-title":"Mitochondrial RNA and DNA alterations in HIV lipoatrophy are linked to antiretroviral therapy and not to HIV infection","volume":"13","author":"McComsey","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.molmed.2010.03.002_bib57","first-page":"114","article-title":"HIV disease progression: immune activation, microbes, and a leaky gut","volume":"15","author":"Douek","year":"2007","journal-title":"Top. HIV Med."},{"key":"10.1016\/j.molmed.2010.03.002_bib58","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1086\/429697","article-title":"In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA","volume":"191","author":"Mallon","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molmed.2010.03.002_bib59","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1210\/jc.2007-0197","article-title":"Reduced adipogenic gene expression in thigh adipose tissue precedes human immunodeficiency virus-associated lipoatrophy","volume":"93","author":"Kratz","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2010.03.002_bib60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1468-1293.2007.00527.x","article-title":"Early changes in adipokine levels and baseline limb fat may predict HIV lipoatrophy over 2 years following initiation of antiretroviral therapy","volume":"9","author":"Calmy","year":"2008","journal-title":"HIV Med."},{"key":"10.1016\/j.molmed.2010.03.002_bib61","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1086\/599986","article-title":"Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy","volume":"200","author":"Sievers","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molmed.2010.03.002_bib62","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1128\/AAC.01449-07","article-title":"Mitochondrial DNA content, an inaccurate biomarker of mitochondrial alteration in human immunodeficiency virus-related lipodystrophy","volume":"52","author":"Kim","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molmed.2010.03.002_bib63","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/jac\/dkp100","article-title":"Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen","volume":"63","author":"Gerschenson","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.molmed.2010.03.002_bib64","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1086\/605440","article-title":"Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA)","volume":"49","author":"Negredo","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2010.03.002_bib65","doi-asserted-by":"crossref","first-page":"E85","DOI":"10.1152\/ajpendo.90224.2008","article-title":"Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy","volume":"295","author":"Sevastianova","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2010.03.002_bib66","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1177\/135965350701200809","article-title":"A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study","volume":"12","author":"Kim","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.molmed.2010.03.002_bib67","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1007\/s00125-004-1508-2","article-title":"In the lipodystrophy associated with highly active antiretroviral therapy, pseudo-Cushing's syndrome is associated with increased regeneration of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue","volume":"47","author":"Sutinen","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmed.2010.03.002_bib68","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bcp.2005.04.015","article-title":"Site specific alterations of adipose tissue mitochondria in 3\u2032-azido-3\u2032-deoxythymidine (AZT)-treated rats: an early stage in lipodystrophy?","volume":"70","author":"Deveaud","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.molmed.2010.03.002_bib69","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/path.1212","article-title":"Multiple symmetric lipomatosis may be the consequence of defective noradrenergic modulation of proliferation and differentiation of brown fat cells","volume":"198","author":"Nisoli","year":"2002","journal-title":"J. Pathol."},{"key":"10.1016\/j.molmed.2010.03.002_bib70","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mad.2006.11.016","article-title":"Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans","volume":"128","author":"Franceschi","year":"2007","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.molmed.2010.03.002_bib71","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.4049\/jimmunol.179.7.4829","article-title":"Aging up-regulates expression of inflammatory mediators in mouse adipose tissue","volume":"179","author":"Wu","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2010.03.002_bib72","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1086\/429295","article-title":"Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders","volume":"191","author":"Tarr","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molmed.2010.03.002_bib73","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1086\/650003","article-title":"Association between HLA-B*4001 and lipodystrophy among HIV-infected patients from Thailand who received a stavudine-containing antiretroviral regimen","volume":"50","author":"Wangsomboonsiri","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2010.03.002_bib74","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/QAI.0b013e3181a324d6","article-title":"Mitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapy","volume":"51","author":"Hendrickson","year":"2009","journal-title":"J. Acquir. Immune. Defic. Syndr."},{"key":"10.1016\/j.molmed.2010.03.002_bib75","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/QAD.0b013e32830b3a96","article-title":"Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy","volume":"22","author":"Zanone Poma","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2010.03.002_bib76","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/sj.tpj.6500374","article-title":"Overview of the pharmacogenetics of HIV therapy","volume":"6","author":"Rodriguez-Novoa","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.molmed.2010.03.002_bib77","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/QAI.0b013e31816d9ba1","article-title":"The associations of regional adipose tissue with lipid and lipoprotein levels in HIV-infected men","volume":"48","author":"Wohl","year":"2008","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.molmed.2010.03.002_bib78","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2337\/dc06-1075","volume":"30","author":"Samaras","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmed.2010.03.002_bib79","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/dc07-2013","article-title":"Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study","volume":"31","author":"De Wit","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmed.2010.03.002_bib80","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/00002030-200307040-00011","article-title":"Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy","volume":"17","author":"Vigouroux","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2010.03.002_bib81","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1468-1293.2009.00720.x","article-title":"Lipoatrophy and lipohypertrophy are independently associated with hypertension","volume":"10","author":"Crane","year":"2009","journal-title":"HIV Med."},{"key":"10.1016\/j.molmed.2010.03.002_bib82","doi-asserted-by":"crossref","unstructured":"Boccara, F. et al. (2010) HIV protease inhibitors activate the adipocyte renin-angiotensin system. Antivir. Ther. 15(3): In press","DOI":"10.3851\/IMP1533"},{"key":"10.1016\/j.molmed.2010.03.002_bib83","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.aids.0000206503.01536.11","article-title":"Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients","volume":"20","author":"Lemoine","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2010.03.002_bib84","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/hep.22665","article-title":"Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy","volume":"49","author":"Ingiliz","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2010.03.002_bib85","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/diacare.27.2.372","article-title":"Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study","volume":"27","author":"Snijder","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmed.2010.03.002_bib86","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mad.2006.11.015","article-title":"Inflammatory networks in ageing, age-related diseases and longevity","volume":"128","author":"Vasto","year":"2007","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.molmed.2010.03.002_bib87","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1532-5415.2007.01584.x","article-title":"Fat and inflammaging: a dual path to unfitness in elderly people?","volume":"56","author":"Florez","year":"2008","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.molmed.2010.03.002_bib88","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/648080","article-title":"Coronary aging in HIV-infected patients","volume":"49","author":"Guaraldi","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2010.03.002_bib89","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/QAD.0b013e328333ea9e","article-title":"Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men","volume":"24","author":"Lo","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2010.03.002_bib90","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1086\/590150","article-title":"Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions","volume":"47","author":"Effros","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2010.03.002_bib91","doi-asserted-by":"crossref","first-page":"373524","DOI":"10.1155\/2009\/373524","article-title":"The effects of thiazolidinediones on metabolic complications and lipodystrophy in HIV-infected patients","volume":"2009","author":"Sutinen","year":"2009","journal-title":"PPAR Res."},{"key":"10.1016\/j.molmed.2010.03.002_bib92","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/135965350801300107","article-title":"Effect of pioglitazone on HIV-1-related lipodystrophy: a randomized double-blind placebo-controlled trial (ANRS 113)","volume":"13","author":"Slama","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.molmed.2010.03.002_bib93","unstructured":"McComsey, G. et al. (2010) A 48-week randomized study of uridine supplementation vs. switch to TDF on limb fat, mitochondrial function, inflammation and bone mineral density in HIV lipoatrophy. In 17th Conference on Retroviruses and Opportunistic Infections, 342"},{"key":"10.1016\/j.molmed.2010.03.002_bib94","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/135965350701200113","article-title":"Uridine supplementation for the treatment of antiretroviral therapy-associated lipoatrophy: a randomized, double-blind, placebo-controlled trial","volume":"12","author":"Sutinen","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.molmed.2010.03.002_bib95","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/01.aids.0000222072.37749.5a","article-title":"Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men--a randomized, placebo-controlled study","volume":"20","author":"Mallon","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2010.03.002_bib96","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/QAD.0b013e32830a5058","article-title":"Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation","volume":"22","author":"Falutz","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2010.03.002_bib97","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/COH.0b013e3281e38a98","article-title":"Atherosclerotic vascular disease in HIV: it is not just antiretroviral therapy that hurts the heart!","volume":"2","author":"van Leuven","year":"2007","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.molmed.2010.03.002_bib98","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1086\/339866","article-title":"Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy","volume":"34","author":"Saves","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2010.03.002_bib99","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/135965350901400203","article-title":"A new era of antiretroviral drug toxicity","volume":"14","author":"Calmy","year":"2009","journal-title":"Antivir. Ther."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491410000377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491410000377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T20:57:49Z","timestamp":1685566669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491410000377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S1471491410000377"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2010.03.002","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}